PLXS - Plexus Corp.
State of Alaska Department of Revenue lessened its holdings in shares of Plexus Corp. (NASDAQ: PLXS) by 39.9% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 6,040 shares of the technology company's stock after selling 4,012 shares during the period. State of Alaska Department of
Shares of Plexus Corp. (NASDAQ: PLXS - Get Free Report) have been assigned a consensus recommendation of "Buy" from the eight ratings firms that are presently covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12
Plexus (NASDAQ: PLXS - Get Free Report) and MultiSensor AI (NASDAQ: MSAI - Get Free Report) are both technology companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk. Institutional and Insider Ownership 94.5% of Plexus shares are
NEENAH, WI, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) announced today it will release its fiscal fourth quarter and fiscal year 2026 results after market close on Wednesday, October 28, 2026. Plexus' management will host a conference call to discuss its fiscal fourth quarter and fiscal year 2026 results on Thursday, October 29, 2026 at 8:30 a.m. Eastern Time. An audio webcast of the call and accompanying slides will be available in the investor relations section of the company website, plexus.com.
Does Plexus (PLXS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Vontier (NYSE: VNT - Get Free Report) and Plexus (NASDAQ: PLXS - Get Free Report) are both mid-cap technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk. Institutional and Insider Ownership 95.8% of Vontier shares are
Plexus (NASDAQ: PLXS - Get Free Report) and 908 Devices (NASDAQ: MASS - Get Free Report) are both technology companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, risk and earnings. Analyst Ratings This is a breakdown of current ratings
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock?
The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in Plexus (PLXS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Deutsche Bank AG purchased a new position in shares of Plexus Corp. (NASDAQ: PLXS) in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 30,495 shares of the technology company's stock, valued at approximately $9,169,000. Deutsche Bank AG owned about 0.11% of Plexus
Oil-price volatility is shaking markets, but Plexus, Twilio and MACOM stand out as momentum stocks with strong one-year gains and recent pullbacks.
Plexus (PLXS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Does Plexus (PLXS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Electronics manufacturing services (EMS) providers are benefiting from a powerful combination of secular technology investment, rising product complexity, and increased outsourcing by original equipment manufacturers (OEMs).
Amundi boosted its holdings in shares of Plexus Corp. (NASDAQ: PLXS) by 143.0% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,294 shares of the technology company's stock after acquiring an additional 18,418 shares during the period.
Plexus is delivering faster growth, higher earnings and wider margins, but premium valuation and weaker near-term cash flow temper the buy case.
PLXS' broad Q3 beat and stronger growth outlook extend its runway, but rising working-capital needs put free cash flow conversion under scrutiny.
Plexus Corp. (NASDAQ: PLXS - Get Free Report) has received a consensus rating of "Moderate Buy" from the seven ratings firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price target
Plexus Corp. (PLXS) Q3 2026 Earnings Call Transcript
Plexus NASDAQ: PLXS reported record fiscal third-quarter revenue of $1.305 billion, exceeding its guidance range and rising 12% sequentially and 28% from a year earlier, as demand strengthened across its aerospace and defense, healthcare life sciences, and industrial markets.